Is the price fair?
What PNTG's price assumes
The Pennant Group, Inc. trades at 45.7× earnings against 19.6× for the median Medical Care Facilities name, more expensive than its own group.
45.7
Trailing P/E · Medical Care Facilities median 19.6 · 2.34× the median: the market pays up for this one
- Price / sales
- 1.07
Price / sales · as of 2026-Q1
- Free cash flow yield
- 4.1%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- +8.4%
Growth the price implies · The price pays for +8.4% free cash flow growth a year for a decade; the business has delivered +85% a year over the last three.
Details›
- EV / EBIT2026-Q1
- 22.1
- EV / sales2026-Q1
- 1.22
- Healthcare median P/E362 names
- 29.9
- Medical Care Facilities median P/E29 names
- 19.6
- Free cash flow, trailing twelve months
- $51M
- Market capitalisation
- $1.25B
- 3-year revenue growth
- +28%
- 3-year free cash flow growth
- +85%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $30.72 |
| Its own P/E history, median | $34.78 |
| Its own P/E history, upper quartile | $98.83 |
| 52-week range | $23.64 – $41.99 |
| Today | $39.33 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Care Facilities
Ranks #12 of 25 by Smart Score